)
Arctic Bioscience (ABS) investor relations material
Arctic Bioscience Q4 2025 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
2025 sales revenue was NOK 39.8 million, a decrease from 2024 due to a significant product recall at the end of 2024, but Q4 2025 saw a strong recovery with NOK 13.9 million in sales and robust order intake for 2026.
B2B segment remained dominant, accounting for nearly 90% of sales, with the US market showing over 140% year-over-year growth and the Americas achieving the highest revenue share at 33%.
Operational cost reductions of NOK 13.6 million improved EBITDA, with adjusted EBITDA for 2025 at NOK -28.3 million, up from NOK -36.8 million in 2024.
Pharma pipeline advanced with positive results in psoriasis and glaucoma studies, and the HeROPA trial demonstrated significant reduction in systemic inflammation, attracting international attention and partnership discussions.
ROMEGA® products expanded into Singapore and Asia, and Arctic Algae project received NOK 2.5 million in funding for oral fish vaccines.
Financial highlights
2025 sales revenue was NOK 39.8 million, down NOK 3.7 million from 2024, with Q4 sales at NOK 13.9 million.
Gross margin for 2025 was 27.1%, stable compared to 2024.
Adjusted EBITDA for 2025 was NOK -28.3 million, an improvement from NOK -36.8 million in 2024.
Available liquidity at year-end was NOK 5.2 million, down from NOK 7 million at the end of 2024.
Operational costs reduced by NOK 13.6 million year-over-year.
Outlook and guidance
Strong order outlook for 2026, with expected growth in nutraceuticals and new product launches in B2B and B2C segments across Europe and Asia.
Continued focus on expanding B2C distribution in Europe and growing presence in Asia, including new markets like India, Japan, and Singapore.
Pharma development to proceed with partners and soft funding, not through direct capital raises.
Data from HeROPA trial to be published and presented in 2026, increasing visibility.
Liquidity situation is closely monitored, with ongoing dialogue with the bank and board oversight.
Next Arctic Bioscience earnings date
Next Arctic Bioscience earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage